High-yield production of lentiviral vector for commercial CAR-T cell therapy : a process transfer from conventional flatware to an innovative fixed-bed bioreactor
CAR-T cell therapies have reshaped the treatment paradigm for hematological cancers, relying on lentiviral vectors (LVVs) to deliver Chimeric Antigen Receptor (CAR) genes into patient T cells. As clinical success […]
Learn more